|
|
 |
 |
CreaGen Biosciences, Inc. is a premier chemistry-based drug discovery service company that provides cost-effective, high quality discovery research services to biotech and pharmaceutical companies. Our discovery research service engine can help transform your research ideas into innovative medicines. We can function as an exclusive medicinal chemistry department to help move your concepts to the clinic.
CreaGen’s unique medicinal chemistry research services for biotechnology and start-up pharmaceutical companies has reduced the initial infrastructure expenses for these partners and delivered high quality and high value preclinical candidates with speed.
|
|
|
|
|
 |
News |
|
 CreaGen Inc. makes into the 2018 list of major players in CRO industry
https://www.businesswire.com/news/home/20180412005808/en/Outsourcing-Drug-Discovery-Contract-Research-Organization-CRO
https://themobileherald.com/contract-research-organization-market-industry-growth-and-forecast-analysis-report-till-2024/24870/
https://www.businesswire.com/news/home/20180412005808/en/Outsourcing-Drug-Discovery-Contract-Research-Organization-CRO
more... |
|
7th Advances In Chemical Sciences Symposium: May 4th, 2018
The Seventh Annual
Advances in Chemical Sciences Symposium
Royal Sonesta Hotel
Cambridge, MA: May 4th, 2018
A day-long symposium focused on Medicinal Chemistry, Organic Synthesis, and Methodology, featuring eminent scientists from industry and academia.
Speakers:
Professor Richard R. Schrock (MIT): “TBA”
Professor Dale L. Boger (Scripps Research Institute): “Redesign of Vancomycin for Resistant Bacteria”
Professor Laura Kiessling (MIT): “TBA”
Dr. Sue Ashwell (Forma Therapeutics): “Discovery and Optimization of a Novel Series of Inhibitors of mt-IDH1”
Dr. Michael Hoemann (Abbvie): “Discovery and Optimization of Spleen Tyrosine Kinase Inhibitors for Immunological Diseases”
Dr. Frank Salituro (Sage Therapeutics): “Discovery and Clinical Development of SAGE-217: A Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (GABA)A Receptor”
Plus:
Vendor Exhibition Hall and Networking Reception
more... |
|
| |
| |
|
